20% of patients with type 2 diabetes mellitus in Qatar have atherosclerotic cardiovascular disease: Study

Doha, Qatar: A recent study conducted by researchers from Hamad Medical Corporation (HMC) in collaboration with researchers from Weill Cornell Medicin...

Related Keywords

Doha ,Ad Daw Ah ,Qatar ,Amin Jayyousi ,Tarik Elhadd ,Rayaz Malik ,Hamad Medical Corporation ,Novo Nordisk ,Weill Cornell Medicine ,Consultant Endocrinologist ,The Peninsula ,